Earnings Call · Q4 FY2023·2024-03-28

Q4 23EPS +40.00%·Rev n/aQ3 23EPS +10.00%·Rev n/aQ2 23EPS -11.11%·Rev n/aQ1 23EPS +10.00%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

Sabrina Martucci Johnson — President

MarDee Haring-Layton — Vice President of Accounting and Finance

−10.7%1d on move date−10.7% vs SPY3d−10.3%5d−7.3%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access